|
WO02057215A2
|
|
Sodium channel modulators
|
|
AU8696501A
|
|
Sodium channel modulators
|
|
CN1441680A
|
|
Cyclodextrin containing glycopeptide antibiotic pharmaceutical compositions
|
|
AU5930301A
|
|
Glycopeptide carboxy-saccharide derivatives
|
|
WO0198326A2
|
|
Glycopeptide disulfide and thioester derivatives
|
|
WO0157071A2
|
|
Glycopeptide derivatives having antibiotic activity
|
|
AU2576501A
|
|
Protein kinase inhibitors
|
|
ZA200005850B
|
|
β2- Adrenergic receptor agonists.
|
|
AU7734700A
|
|
Macrocyclic quinazolinones and their use as local anesthetics
|
|
ZA200004564B
|
|
Novel potassium channel drugs and their uses.
|
|
ZA200004086B
|
|
Multibinding inhibitors of cyclooxygenase-2.
|
|
ZA200003475B
|
|
Muscarinic receptor antagonists.
|
|
AU4665100A
|
|
Novel disaccharide antibacterial agents
|
|
IL140093D0
|
|
Glycopeptide derivatives and pharmaceutical compositions containing the same
|
|
SG87877A1
|
|
Glycopeptide derivatives and pharmaceutical compositions containing the same
|
|
US6420354B1
|
|
Sodium channel drugs and uses
|
|
US6380356B1
|
|
Multivalent polymyxin antibiotics
|
|
US6274716B1
|
|
Combinatorial library of moenomycin analogs and methods of producing same
|
|
SG83735A1
|
|
Novel local anesthetic compounds and uses
|
|
WO9964046A1
|
|
Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
|
